TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34153415

Group type: EXPERIMENTAL
Intervention: 20 min of moderate intensity aerobic exercise
Number of subjects: 2

Group type: COMPARATOR
Intervention: Cognitively engaging control condition
Number of subjects: 2
Study: 36232049

Group type: EXPERIMENTAL
Intervention: Self-applied intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention delivered online by therapists
Number of subjects: 0
Study: 33810808

Group type: EXPERIMENTAL
Intervention: 500 ml pomegranate juice and standard of care hospital treatment for COVID-19
Number of subjects: 48

Group type: COMPARATOR
Intervention: Matching placebo containing 500 ml of red water and standard of care hospital treatment for COVID-19
Number of subjects: 48
Study: 36087608

Group type: EXPERIMENTAL
Intervention: Robotic surgery
Number of subjects: 1171

Group type: COMPARATOR
Intervention: Laparoscopic surgery
Number of subjects: 1171
Study: 32093783

Group type: COMPARATOR
Intervention: Infliximab (TRIPSS)
Number of subjects: 632

Group type: COMPARATOR
Intervention: Hydroxychloroquine (JOQUER)
Number of subjects: 632

Group type: COMPARATOR
Intervention: Rituximab (TEARS)
Number of subjects: 632

Group type: COMPARATOR
Intervention: 5-year follow-up of ASSESS cohort
Number of subjects: 632
Study: 34850000

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM)
Number of subjects: 245
Study: 33393402

Group type: EXPERIMENTAL
Intervention: LoSenseT protocol (sensorimotor training for lower limbs)
Number of subjects: 20
Study: 32697335

Group type: EXPERIMENTAL
Intervention: Glasdegib plus low-dose cytarabine (LDAC)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Low-dose cytarabine (LDAC)
Number of subjects: 116
Study: 616484402

Group type: EXPERIMENTAL
Intervention: Family-Based Smoking Cessation Intervention
Number of subjects: 0
Study: 33601986

Group type: EXPERIMENTAL
Intervention: Narrative Pictorial Warning Labels (PWLs)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Non-narrative Pictorial Warning Labels (PWLs)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Control
Number of subjects: 169
Study: 34527079

Group type: EXPERIMENTAL
Intervention: Oral nutritional supplements (ONSs) with a high‐protein–high‐calorie mixture containing immunonutrients (Impact)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard high‐calorie–high‐protein nutritional blends
Number of subjects: 0
Study: 35618939

Group type: EXPERIMENTAL
Intervention: H2O2 priming (2%)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 3
Study: 34671668

Group type: EXPERIMENTAL
Intervention: Breathlessness service intervention
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Self-referral recruitment through media sources
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Qualitative interviews
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Postal survey
Number of subjects: 183
Study: 32706731

Group type: EXPERIMENTAL
Intervention: Mobile version of the ASES questionnaire
Number of subjects: 50

Group type: COMPARATOR
Intervention: Paper version of the ASES questionnaire
Number of subjects: 50
Study: 35401736

Group type: EXPERIMENTAL
Intervention: Single channel electroencephalogram (EEG) approach through visual‐motor activity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo group (control)
Number of subjects: 0
Study: 32293119

Group type: EXPERIMENTAL
Intervention: Intraarticular injection of trans-capsaicin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36364934

Group type: EXPERIMENTAL
Intervention: HMB + D (3 g Calcium HMB + 2000 IU D per day)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 33106185

Group type: EXPERIMENTAL
Intervention: Manual acupuncture (MA)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Sham acupuncture (SA)
Number of subjects: 118
Study: 35315305

Group type: EXPERIMENTAL
Intervention: HIV risk-reduction intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 33982872

Group type: EXPERIMENTAL
Intervention: Folic acid 5 mg tablet daily for 12 weeks
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo daily for 12 weeks
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Folic acid 5 mg tablet
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study: 32860406

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of bone marrow-derived mononuclear cells (BM-MNCs) 2-8 days after PPCI
Number of subjects: 375

Group type: COMPARATOR
Intervention: Optimal medical therapy
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of bone marrow-derived mononuclear cells (BM-MNCs)
Number of subjects: 375
Study: 35198913

Group type: EXPERIMENTAL
Intervention: Reactive focal mass drug administration (rfMDA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reactive vector control (RAVC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined rfMDA plus RAVC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sero-prevalence as an endpoint
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quantitative polymerase chain reaction (qPCR) prevalence
Number of subjects: 0
Study: 33916192

Group type: EXPERIMENTAL
Intervention: Probiotic preparation comprising Lactobacillus rhamnosus ŁOCK 0900, Lactobacillus rhamnosus ŁOCK 0908, and Lactobacillus casei ŁOCK 0918 at a daily dose of 10^9 bacteria for three months.
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo for three months.
Number of subjects: 151
Study: 34612589

Group type: EXPERIMENTAL
Intervention: Rosemary Online
Number of subjects: 528

Group type: EXPERIMENTAL
Intervention: Slimming World Online
Number of subjects: 528

Group type: EXPERIMENTAL
Intervention: NHS Weight Loss Plan
Number of subjects: 528

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 528
Study: 32448624

Group type: EXPERIMENTAL
Intervention: Tdap vaccination during pregnancy
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group (mothers vaccinated after delivery)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Post booster vaccinations
Number of subjects: 118
Study: 34233065

Group type: EXPERIMENTAL
Intervention: Glycoprotein IIb/IIIa inhibitors (GPI)
Number of subjects: 2378
Study: 34507046

Group type: EXPERIMENTAL
Intervention: Dry Needling (DN)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham-Dry Needling (Sham-DN)
Number of subjects: 50
Study: 34931478

Group type: COMPARATOR
Intervention: Fecal microbiota transplantation (FMT), 4 FMTs each 2 weeks apart after 2 placebo transplantations.
Number of subjects: 9
Study: 32173916

Group type: EXPERIMENTAL
Intervention: guselkumab 100 or 200 mg at weeks 0, 4, 12 and every 8 weeks
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: guselkumab 100 or 200 mg
Number of subjects: 66

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 66
Study: 35675561

Group type: EXPERIMENTAL
Intervention: 2 Mini Dental Implants (2MDI)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 4 Mini Dental Implants (4MDI)
Number of subjects: 37

Group type: COMPARATOR
Intervention: 2 Conventional Dental Implants (2CDI)
Number of subjects: 37
Study: 33731261

Group type: EXPERIMENTAL
Intervention: Journals with Advanced Online Publication (AOP)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Journals without Advanced Online Publication (AOP)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Overall publication speed
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Correlation with Impact Factor (IF) and Article Processing Charges (APCs)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Comparison of IF
Number of subjects: 25
Study: 35927547

Group type: EXPERIMENTAL
Intervention: Individually tailored educational website (CHiCOS)
Number of subjects: 1294

Group type: COMPARATOR
Intervention: Untailored information derived from the Vaccine Information Sheet (VIS)
Number of subjects: 1294

Group type: EXPERIMENTAL
Intervention: Both tailored and untailored combined
Number of subjects: 1294
Study: 33400099

Group type: EXPERIMENTAL
Intervention: Enoxaparin 0.5 mg/kg daily (weight-based dosing)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Enoxaparin 40 mg twice daily
Number of subjects: 80
Study: 32338940

Group type: EXPERIMENTAL
Intervention: Partner-inclusive vulnerability discussions
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Partner-exclusive vulnerability discussions
Number of subjects: 82
Study: 32089486

Group type: EXPERIMENTAL
Intervention: 1-month recall version of the Premature Ejaculation Profile (PEP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short-term event-driven version of the Premature Ejaculation Profile (PEP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravaginal ejaculatory latency time (IELT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical Global Impression of Change (CGIC)
Number of subjects: 0
Study: 35264025

Group type: EXPERIMENTAL
Intervention: Home-based exercise training program (12 weeks duration)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Home-based exercise training program
Number of subjects: 51
Study: 35213415

Group type: EXPERIMENTAL
Intervention: TMB-L + BRAF WT
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: TMB-L + NRAS mut
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: TMB-L tumors
Number of subjects: 85
Study: 34072223

Group type: EXPERIMENTAL
Intervention: One-off application of a structured 5-step implicit process to simplify medication regimens.
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: One-off implicit medication simplification intervention.
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Implementation of simplification recommendations.
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Stakeholder perceptions of regimen simplification.
Number of subjects: 25
Study: 33973009

Group type: EXPERIMENTAL
Intervention: Nutrition-sensitive agroecology intervention
Number of subjects: 591
Study: 32822460

Group type: EXPERIMENTAL
Intervention: Computed Tomography Angiography
Number of subjects: 568

Group type: COMPARATOR
Intervention: Exercise Electrocardiography (ECG) alone
Number of subjects: 568
Study: 36159305

Group type: EXPERIMENTAL
Intervention: Nomogram prognostic model for overall survival (OS)
Number of subjects: 29736

Group type: EXPERIMENTAL
Intervention: Nomogram prognostic model for cancer-specific survival (CSS)
Number of subjects: 29736

Group type: COMPARATOR
Intervention: Nomogram compared to traditional TNM staging
Number of subjects: 29736
Study: 33035492

Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (TXA) 20 mg/kg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intravenous normal saline (0.09%)
Number of subjects: 50
Study: 34181143

Group type: EXPERIMENTAL
Intervention: 1-mg melatonin
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: 4-mg melatonin
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study: 32449924

Group type: EXPERIMENTAL
Intervention: Ixekizumab
Number of subjects: 8228
Study: 33392653

Group type: EXPERIMENTAL
Intervention: 3D endoscopy
Number of subjects: 16

Group type: COMPARATOR
Intervention: 2D endoscopy
Number of subjects: 16
Study: 35190270

Group type: EXPERIMENTAL
Intervention: Lemon essential oil (smelled for 15 min)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 46
Study: 34859852

Group type: EXPERIMENTAL
Intervention: Standard treatment plus Vitamin D supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment without Vitamin D
Number of subjects: 0
Study: 32200759

Group type: EXPERIMENTAL
Intervention: Healthcare delivery model targeting multiple stroke risk factors
Number of subjects: 275

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Both arms (experimental and usual care)
Number of subjects: 275
Study: 34033212

Group type: EXPERIMENTAL
Intervention: Ipragliflozin 50 mg once daily
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study: 32485753

Group type: EXPERIMENTAL
Intervention: Participants told the patient was hypotensive
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Participants told the patient was hypertensive
Number of subjects: 85
Study: 33774696

Group type: EXPERIMENTAL
Intervention: Genetically predicted self-reported moderate to vigorous physical activity (PA)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Genetically predicted accelerometer-based physical activity
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Genetically predicted accelerometer fraction of accelerations > 425 milli-gravities
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Genetically predicted sedentary behavior
Number of subjects: 42
Study: 32155878

Group type: EXPERIMENTAL
Intervention: Low FODMAP diet that was also gluten-free (low FODMAP-GFD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Gluten/placebo challenge
Number of subjects: 30
Study: 35334848

Group type: EXPERIMENTAL
Intervention: Saw palmetto berry extract (SPE) for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32864597

Group type: EXPERIMENTAL
Intervention: Evening-Night Closed-Loop Control (E-N CLC)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 24-7 Closed-Loop Control (24-7 CLC)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sensor-Augmented Pump Therapy (SAP)
Number of subjects: 80
Study: 35289723

Group type: EXPERIMENTAL
Intervention: HIIE (4 × 4 minutes on cycle ergometer with 3 minutes active recovery)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control (relaxed for the time equivalent to intervention)
Number of subjects: 49
Study: 32917540

Group type: EXPERIMENTAL
Intervention: Music during surgical task
Number of subjects: 19

Group type: COMPARATOR
Intervention: No music during surgical task
Number of subjects: 19

Group type: COMPARATOR
Intervention: Comparison of music vs no music
Number of subjects: 19
Study: 32101272

Group type: EXPERIMENTAL
Intervention: Pancreaticogastrostomy (PG) with externalized stent
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Pancreaticojejunostomy (PJ) with externalized stent
Number of subjects: 72
Study: 36307274

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Lifestyle plus medication therapy management
Number of subjects: 188

Group type: COMPARATOR
Intervention: Social services
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: All three groups
Number of subjects: 188
Study: 34902548

Group type: EXPERIMENTAL
Intervention: Therapeutic immersive pain relief skills VR program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham VR program
Number of subjects: 0
Study: 32456702

Group type: EXPERIMENTAL
Intervention: Informative video
Number of subjects: 1024

Group type: COMPARATOR
Intervention: Control group (no video)
Number of subjects: 1024
Study: 35913904

Group type: EXPERIMENTAL
Intervention: Linear pedagogy
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Nonlinear pedagogy
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control
Number of subjects: 162
Study: 35587681

Group type: EXPERIMENTAL
Intervention: Nitrous oxide/oxygen inhalation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dexmedetomidine combined with flurbiprofen axetil sedation and analgesia
Number of subjects: 60
Study: 33001381

Group type: EXPERIMENTAL
Intervention: Spatz3® adjustable intragastric balloon (IGB) with upward adjustment (250 mL greater volume)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Spatz3® adjustable intragastric balloon (IGB) with constant volume (600 mL)
Number of subjects: 180
Study: 35820753

Group type: EXPERIMENTAL
Intervention: Group aerobic exercise delivered by exercise professionals and supported by mental health workers for 1 hour three times a week for 12 weeks
Number of subjects: 122

Group type: COMPARATOR
Intervention: Leisure activities led by mental health workers for 1 hour three times a week for 12 weeks (Control)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Group aerobic exercise
Number of subjects: 122
Study: 34407530

Group type: EXPERIMENTAL
Intervention: CytoSorb hemoperfusion
Number of subjects: 10
Study: 36083392

Group type: EXPERIMENTAL
Intervention: Combined Physical Training (CPT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control
Number of subjects: 16
Study: 32562076

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) at 200-mW, 6-J, continuous-wave mode for 30 seconds
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 45
Study: 36045520

Group type: EXPERIMENTAL
Intervention: Midazolam and Propofol
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Midazolam and Ketamine
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Midazolam, Ketamine, and Magnesium
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control group (Midazolam)
Number of subjects: 155
Study: 33902519

Group type: EXPERIMENTAL
Intervention: Contact-based intervention group (N=59; communicating with PDS and attending the lecture)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Educational lecture group (N=56; only attending a lecture on schizophrenia)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Contact-based intervention group (N=59)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Educational lecture group (N=56)
Number of subjects: 115
Study: 35988206

Group type: EXPERIMENTAL
Intervention: Papaverine infusion through aortic root
Number of subjects: 86

Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 86
Study: 32503620

Group type: EXPERIMENTAL
Intervention: Lopinavir/Ritonavir (Kaletra) + Colchicine 1.5 mg loading then 0.5 mg twice daily orally
Number of subjects: 80

Group type: COMPARATOR
Intervention: Lopinavir/Ritonavir (Kaletra)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Lopinavir/Ritonavir (Kaletra) + Colchicine
Number of subjects: 80
Study: 33259999

Group type: EXPERIMENTAL
Intervention: Transvaginal high-intensity focused ultrasound (vHIFU) therapy
Number of subjects: 13
Study: 32827221

Group type: EXPERIMENTAL
Intervention: 1Hz rTMS
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 25Hz rTMS
Number of subjects: 51

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 51
Study: 35947124

Group type: EXPERIMENTAL
Intervention: Cooperative practice
Number of subjects: 60

Group type: COMPARATOR
Intervention: Individual practice
Number of subjects: 60
Study: 33877743

Group type: EXPERIMENTAL
Intervention: Doxycycline (100 mg daily for 7 days)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Roxithromycin (300 mg daily for 7 days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no antibiotics given)
Number of subjects: 30
Study: 32393964

Group type: EXPERIMENTAL
Intervention: Bevacizumab (BEV)
Number of subjects: 396

Group type: COMPARATOR
Intervention: Non-Bevacizumab (non-BEV)
Number of subjects: 396
Study: 32969703

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) program, 8-week duration
Number of subjects: 29

Group type: COMPARATOR
Intervention: Active control intervention
Number of subjects: 29
Study: 36184023

Group type: EXPERIMENTAL
Intervention: n‐3 long‐chained polyunsaturated fatty acid (n‐3 LCPUFA) (fish oil)
Number of subjects: 736

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D (2800 IU/d)
Number of subjects: 736
Study: 33309538

Group type: EXPERIMENTAL
Intervention: CB-Abst (cannabis abstinence through contingency management)
Number of subjects: 160

Group type: COMPARATOR
Intervention: CB-Mon (monitoring with no abstinence requirement)
Number of subjects: 160
Study: 32539288

Group type: EXPERIMENTAL
Intervention: 33% of daily TAF (25 mg)/FTC (200 mg)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 67% of daily TAF (25 mg)/FTC (200 mg)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 100% of daily TAF (25 mg)/FTC (200 mg)
Number of subjects: 37
Study: 32451321

Group type: EXPERIMENTAL
Intervention: Bioresorbable vascular scaffold (BVS)
Number of subjects: 1670

Group type: COMPARATOR
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 1670
Study: 35379302

Group type: EXPERIMENTAL
Intervention: Mirasol-treated whole blood (n = 1000)
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Standard whole blood (n = 1000)
Number of subjects: 2000
Study: 33104016

Group type: EXPERIMENTAL
Intervention: Diagonal eccentric contraction intervention (IEDEC)
Number of subjects: 25

Group type: COMPARATOR
Intervention: General exercise intervention (IGE)
Number of subjects: 25
Study: 32619212

Group type: EXPERIMENTAL
Intervention: Psyllium
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Wheat bran
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Nopal
Number of subjects: 14
Study: 35399102

Group type: EXPERIMENTAL
Intervention: Self-efficacy enhancing intervention
Number of subjects: 150
Study: 33439219

Group type: EXPERIMENTAL
Intervention: PE-owned clinics (BCBS)
Number of subjects: 1833

Group type: EXPERIMENTAL
Intervention: PE-owned clinics (Medicare)
Number of subjects: 1833

Group type: COMPARATOR
Intervention: Control clinics (BCBS)
Number of subjects: 1833

Group type: COMPARATOR
Intervention: Control clinics (Medicare)
Number of subjects: 1833

Group type: EXPERIMENTAL
Intervention: PE-owned clinics (Medicaid)
Number of subjects: 1833

Group type: COMPARATOR
Intervention: Control clinics (Medicaid)
Number of subjects: 1833

Group type: EXPERIMENTAL
Intervention: PE-owned clinics (new patient appointments with NPCs)
Number of subjects: 1833

Group type: COMPARATOR
Intervention: Control clinics (new patient appointments with NPCs)
Number of subjects: 1833

Group type: EXPERIMENTAL
Intervention: PE-owned clinics (next-day appointment availability)
Number of subjects: 1833

Group type: COMPARATOR
Intervention: Control clinics (next-day appointment availability)
Number of subjects: 1833
Study: 33565885

Group type: EXPERIMENTAL
Intervention: LSG + PF (posterior fixation with fibrin tissue glue)
Number of subjects: 191

Group type: COMPARATOR
Intervention: LSG alone (traditional technique)
Number of subjects: 191
Study: 34507074

Group type: EXPERIMENTAL
Intervention: Rapid streptococcal antigen test
Number of subjects: 519

Group type: COMPARATOR
Intervention: Usual diagnostic‐therapeutic algorithm (Control)
Number of subjects: 519

Group type: COMPARATOR
Intervention: Control group (Usual diagnostic‐therapeutic algorithm)
Number of subjects: 519
Study: 35318006

Group type: EXPERIMENTAL
Intervention: Targeted temperature management at 33 °C for 24 hours
Number of subjects: 159

Group type: COMPARATOR
Intervention: Targeted normothermia at 37 °C for 48 hours
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Targeted temperature management at 33 °C
Number of subjects: 159

Group type: COMPARATOR
Intervention: Targeted normothermia at 37 °C
Number of subjects: 159